Home
>
National Drug Code (NDC)
>
CICLOPIROX
CICLOPIROX - 0574-2061-45 - (CICLOPIROX)
Drug Information of CICLOPIROX
| Product NDC: | 0574-2061 |
| Proprietary Name: | CICLOPIROX |
| Non Proprietary Name: | CICLOPIROX |
| Active Ingredient(s): | 7.7 mg/g & nbsp; CICLOPIROX |
| Administration Route(s): | TOPICAL |
| Dosage Form(s): | GEL |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of CICLOPIROX
| Product NDC: | 0574-2061 |
| Labeler Name: | Paddock Laboratories, Inc. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA078266 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 20090107 |
Package Information of CICLOPIROX
| Package NDC: | 0574-2061-45 |
| Package Description: | 1 TUBE in 1 CARTON (0574-2061-45) > 45 g in 1 TUBE |
NDC Information of CICLOPIROX
| NDC Code | 0574-2061-45 |
| Proprietary Name | CICLOPIROX |
| Package Description | 1 TUBE in 1 CARTON (0574-2061-45) > 45 g in 1 TUBE |
| Product NDC | 0574-2061 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | CICLOPIROX |
| Dosage Form Name | GEL |
| Route Name | TOPICAL |
| Start Marketing Date | 20090107 |
| Marketing Category Name | ANDA |
| Labeler Name | Paddock Laboratories, Inc. |
| Substance Name | CICLOPIROX |
| Strength Number | 7.7 |
| Strength Unit | mg/g |
| Pharmaceutical Classes | Decreased DNA Replication [PE],Decreased Protein Synthesis [PE],Decreased RNA Replication [PE],Protein Synthesis Inhibitors [MoA] |
